The Evaluation of the Local Tolerance of Vaginal Formulations, with or without Nonoxynol-9, Using the Slug Mucosal Irritation Test

Sexually Transmitted Diseases

Volumn 31, Issue 4, 2004, Pages 229-235

  Dhondt, Marijke M M ^a   Adriaens, Els ^a   Remon, Jean Paul ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANTAGE S; CONTRACEPTIVE AGENT; HYDROXYETHYLCELLULOSE; K Y JELLY; LUBRICATING AGENT; NONOXINOL 9; PROTECTAID; REPLENS;

ARTICLE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TOLERABILITY; ENZYME RELEASE; HUMAN; MALE; MEMBRANE DAMAGE; PROTEIN SECRETION; SKIN IRRITATION; UTERINE CERVIX MUCUS; VAGINA MUCOSA; VAGINA SECRETION; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MOLLUSCA; MUCOUS MEMBRANE; NONOXYNOL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPERMATOCIDAL AGENTS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 1642463880     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000118422.62336.FA     Document Type: Article

References (29)

1. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4:165-170.
2. Stafford MK, Ward H, Flanagan A, et al. Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 17:327-331.
3. Stephenson J. Widely used spermicide may increase, not decrease, risk of HIV transmission. JAMA 2000; 284:949-949.
4. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 2001; 184:418-428.
5. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 2002; 360:971-977.
6. The International Working Group on Vaginal Microbicides. Recommendations for the development of vaginal microbicides. AIDS 1996; 10:UNAIDS1-UNAIDS6.
7. Hicks DR, Martin LS, Getchell JP, et al. Inactivation of HTLV-III LAV-infected cultures of normal human-lymphocytes by nonoxynol-9 in vitro. Lancet 1985; 2:1422-1423.
8. Harrison C, Chantler E. The effect of nonoxynol-9 and chlorhexidine on HIV and sperm in vitro. Int J STD AIDS 1998; 9:92-97.
9. European Commission. Non-clinical Local Tolerance Testing of Medicinal Products (Directive 75/318/EEC). Eudralex 3BS12a; 1998:107-116.
10. Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides-Comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis 2002; 29:597-605.
11. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 2002; 29:655-664.
12. Chvapil M, Droegemueller W, Owen JA, Eskelson CD, Betts K. Studies of nonoxynol-9. 1: The effect on the vaginas of rabbits and rats. Fertil Steril 1980; 33:445-450.
13. Patton DL, Kidder GG, Sweeney YC, Rabe LK, Hillier SL. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol 1999; 180:1080-1087.
14. Maguire RA, Bergman N, Phillips DM. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis 2001; 28:259-265.
15. Balls M, Goldberg AM, Fentem JH, et al. The three Rs: The way forward-The report and recommendations of ECVAM workshop 11. Altern Lab Anim 1995; 23:838-866.
16. Adriaens E, Remon JP. Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs. Pharm Res 1999; 16:1240-1244.
17. Adriaens E, Remon JP. The evaluation of an alternative mucosal irritation test using slugs. Toxicol Appl Pharmacol 2002; 182:169-175.
18. Callens C, Adriaens E, Dierckens K, Remon JP. Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol® 974 P on rabbit nasal mucosa and slug mucosa. J Control Release 2001; 76:81-91.
19. Adriaens E, Ameye D, Dhondt MMM, Foreman P, Remon JP. Evaluation of the mucosal irritation potency of co-spray dried Amioca®/Poly(acrylic acid) and Amioca®/Carbopol® 974P mixtures. J Control Release 2003; 88:393-399.
20. Ballagh SA, Baker JM, Henry DM, Archer DF. Safety of single daily use for one week of C31G HEC gel in women. Contraception 2002; 66:369-375.
21. Van Damme L, Chandeying V, Ramjee G, et al. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. AIDS 2000; 14:85-88.
22. Deutsche Gesellschaft für Klinische Chemie. Standardisierung von methoden zur bestimmung von enzymaktivitäten in biologischen flüssigkeiten. Z Klin Chem Klin Biochem 1972; 10:182.
23. Poindexter AN, Levine H, Sangi-Haghpeykar H, et al. Comparison of spermicides on vulvar, vaginal, and cervical mucosa. Contraception 1996; 53:147-153.
24. Mauck C, Weiner DH, Ballagh S, et al. Single and multiple exposure tolerance study of cellulose sulfate gel: A phase I safety and colposcopy study. Contraception 2001; 64:383-391.
25. Balzarini J, Naesens L, Verbeken E, et al. Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent. AIDS 1998; 12:1129-1138.
26. Van Damme L, Niruthisard S, Atisook R, et al. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS 1998; 12:433-437.
27. Creatsas G, Elsheikh A, Colin P. Safety and tolerability of the new contraceptive sponge Protectaid®. Eur J Contracept Reprod Health Care 2002; 7:91-95.
28. Bruner LH, Carr GJ, Chamberlain M, Curren RD. Validation of alternative methods for toxicity testing. Toxicol In Vitro 1996; 10:479-501.
29. Adriaens E, Dierckens K, Bauters TGM, et al. The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs. Pharm Res 2001; 18:937-942.